MannKind Corporation to Present at The Piper Jaffray 25th Annual Healthcare
Piper Jaffray Healthcare Conference 2013
VALENCIA, Calif. -- November 27, 2013
MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and
commercializing treatments for diabetes, announced today that it will present
at The Piper Jaffray 25th Annual Healthcare Conference on Wednesday, December
4, 2013 at 10:00 AM (ET) at The New York Palace, New York, New York.
Interested parties can access a link to the live webcast of the presentations
from the News & Events section of the Company's website at
About MannKind Corporation
MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and
commercialization of therapeutic products for patients with diseases such as
diabetes. Its lead product candidate, AFREZZA®, has completed Phase 3 clinical
trials. MannKind maintains a website at www.mannkindcorp.com to which MannKind
regularly posts copies of its press releases as well as additional information
about MannKind. Interested persons can subscribe on the MannKind website to
e-mail alerts that are sent automatically when MannKind issues press releases,
files its reports with the Securities and Exchange Commission or posts certain
other information to the website.
Chief Financial Officer
Press spacebar to pause and continue. Press esc to stop.